L. Clément

发表

Clinical experience of bendamustine in relapsed or refractory Hodgkin lymphoma: a retrospective analysis of the French compassionate use program in 28 patients

A. Stamatoullas, O. Casasnovas, J. Gabarre, 2013, Leukemia & lymphoma.

Adenovirus-specific T-cell Subsets in Human Peripheral Blood and After IFN-&ggr; Immunomagnetic Selection

M. De Carvalho Bittencourt, L. Reppel, J. Stoltz, 2016, Journal of immunotherapy.

Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.

M. De Carvalho Bittencourt, J. Stoltz, D. Bensoussan, 2014, Cytotherapy.

Focal nodular hyperplasia of the liver following hematopoietic SCT

P. Bordigoni, A. Salmon, C. Baumann, 2009, Bone Marrow Transplantation.

Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008).

R. Porcher, M. Mohty, G. Socié, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Successful management with clofarabine for refractory leukaemia in a young adult with chronic renal failure

A. Kimmoun, A. Salmon, P. Chastagner, 2011, American journal of hematology.

Reduced-intensity versus myeloablative conditioning in cord blood transplantation for AML (40-60 years) across highly mismatched HLA barriers - On behalf of Eurocord and the Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMT.

J. Sierra, D. Blaise, C. Chabannon, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Severe acute GvHD following administration of ipilimumab for early relapse of AML after haploidentical stem cell transplantation

E. Forcade, A. Bidet, N. Milpied, 2017, Bone Marrow Transplantation.

Effect of graft source on unrelated donor hemopoietic stem cell transplantation in adults with acute myeloid leukemia after reduced-intensity or nonmyeloablative conditioning: a study from the Société Francaise de Greffe de Moelle et de Thérapie Cellulaire.

P. Chevallier, I. Yakoub-Agha, D. Blaise, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chimerism analysis following nonmyeloablative stem cell transplantation using a new cell subset separation method: Robosep.

D. Bensoussan, T. Lecompte, P. Bordigoni, 2008, Bio-medical materials and engineering.

Evaluation of schistocyte monitoring after haematopoietic stem cell transplantation

T. Lecompte, P. Bordigoni, J. Lesesve, 2011, International journal of laboratory hematology.

The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation.

J. Stoltz, D. Bensoussan, P. Bordigoni, 2011, Transplant immunology.

Treatment of Relapse After Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndrome: A Large-Scale Study On Behalf of the Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

M. Robin, I. Yakoub-Agha, D. Blaise, 2012 .

Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-T

J. Bourhis, P. Chevallier, I. Yakoub-Agha, 2016, Bone Marrow Transplantation.

Rapid Generation of Full Clinical-Grade Human Antiadenovirus Cytotoxic T Cells for Adoptive Immunotherapy

J. Stoltz, D. Bensoussan, C. Cambouris, 2010, Journal of immunotherapy.

Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient: case report and review of the literature.

P. Bordigoni, A. Salmon, F. Plénat, 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient: case report and review of the literature

P. Bordigoni, A. Salmon, F. Plénat, 2009 .

[Imaging of serious visceral forms of mucormycosis in five immunodepressed patients].

D. Mandry, P. Bordigoni, M. Claudon, 2007, Journal de radiologie.

Osteochondroma after pediatric hematopoietic stem cell transplantation: report of eight cases

P. Lascombes, P. Bordigoni, B. Leheup, 2002, Bone Marrow Transplantation.

Complete recovery from Cryptosporidium parvum infection with gastroenteritis and sclerosing cholangitis after successful bone marrow transplantation in two brothers with X-linked hyper-IgM syndrome

P. Feugier, F. Barbé, D. Bensoussan, 2003, Bone Marrow Transplantation.

Management of Myelodysplastic Syndrome Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: A Study by the French Society of Bone Marrow Transplantation and Cell Therapies.

M. Robin, P. Chevallier, I. Yakoub-Agha, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia

G. Mufti, S. Iacobelli, N. Russell, 2022, New England Journal of Medicine.

M. Bernard, P. Chevallier, I. Yakoub-Agha, 2016, Haematologica.

Decreased nonrelapse mortality after unrelated cord blood transplantation for acute myeloid leukemia using reduced-intensity conditioning: a prospective phase II multicenter trial.

S. Chevret, P. Chevallier, I. Yakoub-Agha, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy.

M. Robin, P. Chevallier, I. Yakoub-Agha, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial

M. De Carvalho Bittencourt, L. Reppel, D. Bensoussan, 2017, Journal of Hematology & Oncology.

Double Cord Blood Transplantation: Incidence, Organ Involvement and Risk Factors of Acute Graft Versus Host Disease. a Retrospective Analysis on Behalf of Eurocord, ALWP and Cqwp-EBMT

J. Bourhis, C. Craddock, M. Labopin, 2014 .

Extracorporeal photopheresis for GVHD prophylaxis after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation: a prospective multicenter phase 2 study

I. Yakoub-Agha, P. Rohrlich, F. Barraco, 2018, Leukemia & lymphoma.

Daclizumab, an efficient treatment for steroid‐refractory acute graft‐versus‐host disease

P. Feugier, P. Bordigoni, A. Salmon, 2006, British journal of haematology.

Human Herpesvirus 6 Infection After Allogeneic Stem Cell Transplantation: Incidence, Outcome, and Factors Associated With HHV-6 Reactivation

P. Bordigoni, N. Agrinier, A. Salmon, 2013, Transplantation.

Prophylactic Extracorporeal Photopheresis for Gvhd Prevention after Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation from Identical Siblings and 10/10 HLA Unrelated Hematopoietic Stem Cells Donors

I. Yakoub-Agha, P. Rohrlich, F. Barraco, 2014 .

Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

M. Robin, I. Yakoub-Agha, M. Mohty, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of disease status and stem cell source on the results of reduced intensity conditioning transplant for Hodgkin’s lymphoma: a retrospective study from the French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

R. Porcher, J. Bourhis, M. Bernard, 2013, Haematologica.

J. Bourhis, P. Chevallier, I. Yakoub-Agha, 2018, American journal of hematology.

Reduced-toxicity myeloablative conditioning regimen using fludarabine and full doses of intravenous busulfan in pediatric patients not eligible for standard myeloablative conditioning regimens: Results of a multicenter prospective phase 2 trial

M. Labopin, M. Mohty, P. Rohrlich, 2022, Bone Marrow Transplantation.

Chromosomally integrated HHV-6: slow decrease of HHV-6 viral load after hematopoietic stem-cell transplantation.

P. Bordigoni, M. Béri, A. Salmon, 2009, Transplantation.

VANDA regimen followed by blinatumomab leads to favourable outcome in patients with Philadelphia chromosome‐negative B‐precursor acute lymphoblastic leukaemia in first relapse

E. Forcade, A. Pigneux, P. Dumas, 2022, British journal of haematology.

M. Labopin, P. Chevallier, M. Mohty, 2014 .

Successful management with clofarabine for refractory leukaemia in a young adult with chronic renal failure

A. Kimmoun, A. Salmon, P. Chastagner, 2011, American journal of hematology.

Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy.

M. Robin, P. Chevallier, I. Yakoub-Agha, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.